Discontinued — last reported Q4 '25
Colgate-Palmolive Interest Paid increased by 174.3% to $96.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.9%, from $109.00M to $96.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 8.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.50M | $48.50M | $48.50M | $37.75M | $37.75M | $37.75M | $37.75M | $94.00M | $35.00M | $114.00M | $37.00M | $123.00M | $38.00M | $106.00M | $35.00M | $109.00M | $28.00M | $98.00M | $35.00M | $96.00M |
| QoQ Change | — | +0.0% | +0.0% | -22.2% | +0.0% | +0.0% | +0.0% | +149.0% | -62.8% | +225.7% | -67.5% | +232.4% | -69.1% | +178.9% | -67.0% | +211.4% | -74.3% | +250.0% | -64.3% | +174.3% |
| YoY Change | — | — | — | — | -22.2% | -22.2% | -22.2% | +149.0% | -7.3% | +202.0% | -2.0% | +30.9% | +8.6% | -7.0% | -5.4% | -11.4% | -26.3% | -7.5% | +0.0% | -11.9% |